Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Budget missteps can erode savings fast. This introduction highlights key mistakes and simple fixes to safeguard your funds.
27,863 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A recall at Aldi impacts 500k packages macaroni cheese after soy lecithin was left undeclared on labels. Consumers sh...
Nvidia’s CEO just handed investors a fresh signal about AI demand and Nvidia’s path forward. This guide breaks down t...
When Alphabet joins the Dow Jones Industrial Average, it signals a shift in how blue-chip names are chosen and weight...
As market volatility lingers in 2026, the timing of Social Security claims tied to birthdays can dramatically alter m...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Retirees seeking reliable, recurring income can benefit from a small, focused trio of high-yielding dividend stocks. ...
Many investors hoped the Trumpflation era was fading. This in-depth guide explains why wall street thinks trumpflatio...
A new mobile AI for health claims to run entirely on your device, delivering medical insights faster and with far les...
Salesforce just announced a massive buyback, but does that mean now is the time to buy CRM stock? This guide breaks d...
Sandisk stock fell today after an upbeat start as investors weighed AI memory tech prospects against inflation jitter...
Brookfield is quietly expanding its private debt platform, aiming to become a major player in private credit. This ar...